[ad_1]
Beximco Pharmaceuticals and SKF Pharmaceuticals, two national companies, have completed production of the “effective” antiviral drug “remedicivir” against coronavirus. Other preparations that include the manufacturing process include Beacon Pharmaceuticals, Incepta Pharmaceuticals, Healthcare Pharmaceuticals and Square Pharmaceuticals, Popular and Opsonin.
The companies reported that the ‘remedicivir’ carried out by some companies in the country could hit the market in the middle of this month. ‘Remedicivir’ is an antiviral medication. Originally used during Ebola, it is now licensed by the United States Food and Drug Administration (FDA).
However, at the time of the coronavirus outbreak, the problem of obtaining medications was alleviated, but was feared for the price. The Drug Administration Department says it cannot control the prices of any of the 118 drugs prescribed by the government. Companies set the price for those drugs. The companies have set the price of each injection of “Remedicivir” at Rs.
Injection item ‘Remedicivir’, will be used only for the treatment of complicated patients in the hospital. The injection of “Remedacivir” should be administered in a period of five to 10 days. Speaking to SKF, Incepta and Beacon Pharma, it is known that the price of the medicines produced by them will be five thousand five hundred rupees. In other words, those who will use this medicine for five days will have to spend 26 thousand rupees. And if you do it in 10 days, it will cost you 55,000 rupees. The companies say that the global market situation, raw materials and other factors are the main reasons for the high price of the drug.
Incepta Pharmaceuticals Deputy Marketing Manager. Mizanur Rahman told the Bengali Tribune: “The name of this medicine that we have made will be Ninovir. It will come to the market soon. The price of each injection has been kept at five thousand five hundred rupees. When asked if the price was higher, He said: “We believe that on other occasions it would have been a quarter of the current price.” But at present, Remdesivir’s raw material is “too expensive.” He said that if any injection is liquid, the price is lower, if it is in good shape. of powder, then the price is higher. Because the manufacturing process or its powder “ingredients” is a little expensive. That is why everyone is forced to keep prices high. “
Beximco Pharmaceuticals and SKF have already submitted samples of their products to the Drug Administration Department, said Ruhul Amin, director of the department. He said that Beximco’s drug testing had already begun. SKF samples have just been sent. Maybe the test will start today (Saturday) or tomorrow. Now, if everything goes well in this test, they will be allowed to market.
However, when asked what the Department of Drug Administration should do in case of concern about the prices of these drugs, Ruhul Amin told the Bengali Tribune that the government sets prices for all 116 drugs on the Primary Care list of Health and companies set prices. These medications are off the government prescribed list.
He said the drug was planned to be supplied only to dedicated Kovid-19 hospitals, but was later allowed to be marketed privately. However, they have also given the condition that this medicine is not sold without the advice of a specialist doctor. He said that these drugs cannot be sold at retail in pharmacies.
Manjurul Alam, director (global business) of Beacon Pharmaceuticals Limited, told the Bengali Tribune that the drug they have developed will be called Pendovir. It could hit the market in mid-June. RemedicV injectable items will cost a lot. And it is only for complex hospitalized patients.
He said that Pendovi will be sold for five thousand five hundred rupees. A patient will need five to 10 injections. You will need Rs 60,000. If the government had “removed” everything from the import tariff on raw materials, these drugs would have been available in the country at a slightly lower price.
On the other hand, SKF (Marketing and Sales) Director Mujahidul Islam told the Bangla Tribune that, depending on the ‘severity’, it should be used for five to 10 days. The name of the medicine made by them will be Remivir. The price will be five thousand five hundred rupees. When asked about the higher prices, he said that prices have been maintained taking into account other factors, including raw materials. Not only SKF, almost all companies have set the same price.
When asked if “RemedicVir” would actually play a role in treating the crown, Dr. Zahidur Rahman told the Bengali Tribune that the use of remedicivir has not been approved by any country so far and has not been brought to held no trial in any country. This is a purely experimental subject. There is nothing to be optimistic about.
[ad_2]
